Clover Health Investments Dirección
Dirección controles de criterios 2/4
El CEO de Clover Health Investments' es Andrew Toy , nombrado en Jan 2023, tiene una permanencia de 1.25 años. compensación anual total es $10.17M, compuesta por 4.9% salario y 95.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.45% de las acciones de la empresa, por valor de $1.44M. La antigüedad media del equipo directivo y de la junta directiva es de 1.5 años y 3.2 años, respectivamente.
Información clave
Andrew Toy
Chief Executive Officer (CEO)
US$10.2m
Compensación total
| Porcentaje del salario del CEO | 6.9% |
| Permanencia del CEO | 1.3yrs |
| Participación del CEO | 0.4% |
| Permanencia media de la dirección | 1.8yrs |
| Promedio de permanencia en la Junta Directiva | 3.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues
Apr 20
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year
Mar 16Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?
Mar 06Clover Health: Its Luck May Have Ran Out
Feb 26Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Nov 21We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely
Jul 07Chamath Palihapitiya-linked Clover Health Investments trading near all-time low
Oct 14Chamath Palihapitiya cuts stake in Clover Health to under 5%
Oct 04Rethinking My Clover Health Position
Sep 12Clover Paid The Price Of Its Alleged Lies; Time To Move On
Aug 17Clover Health Investments to name president Andrew Toy as CEO
Aug 08Clover Health Is A Buy Ahead Of Earnings
Jul 29Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2
Jul 15Is Clover Health A Good Healthcare Sector Stock Pick?
Jun 30Clover Set To Report Earnings Tonight: Levels To Watch
May 09Analysts Are Betting On Clover Health Investments, Corp. (NASDAQ:CLOV) With A Big Upgrade This Week
Mar 04Good News From Clover Health
Feb 25Clover Health Is Now Undervalued, But Gains Not Guaranteed
Jan 24Clover Health: Roles Reversed As Institutions Buy The Dip And Retail Investors Bottle Out
Dec 03Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$10m | US$700k | -US$213m |
| Sep 30 2023 | n/a | n/a | -US$226m |
| Jun 30 2023 | n/a | n/a | -US$260m |
| Mar 31 2023 | n/a | n/a | -US$336m |
| Dec 31 2022 | US$10m | US$500k | -US$340m |
| Sep 30 2022 | n/a | n/a | -US$443m |
| Jun 30 2022 | n/a | n/a | -US$402m |
| Mar 31 2022 | n/a | n/a | -US$615m |
| Dec 31 2021 | US$142m | US$450k | -US$588m |
| Sep 30 2021 | n/a | n/a | -US$527m |
| Jun 30 2021 | n/a | n/a | -US$487m |
| Mar 31 2021 | n/a | n/a | -US$160m |
| Dec 31 2020 | US$9m | US$415k | -US$136m |
| Sep 30 2020 | n/a | n/a | -US$89m |
| Jun 30 2020 | n/a | n/a | -US$145m |
| Mar 31 2020 | n/a | n/a | -US$272m |
| Dec 31 2019 | US$424k | US$400k | -US$364m |
Compensación vs. Mercado: La compensación total de Andrew($USD10.17M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD2.37M).
Compensación vs. Ingresos: La compensación de Andrew ha sido consistente con los resultados de la empresa en el último año.
CEO
Andrew Toy (44 yo)
1.3yrs
Permanencia
US$10,154,701
Compensación
Mr. Andrew Toy Co-founded Clover Health Investments, Corp. and serves as its Director since November 2018 and served as its President since March 2019. He serves as Chief Executive Officer at Clover Health...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 9.8yrs | sin datos | 17.91% $ 65.7m | |
| Co-Founder | 1.3yrs | US$10.15m | 0.45% $ 1.6m | |
| General Counsel | less than a year | US$1.47m | 0.028% $ 101.8k | |
| Chief Executive Officer of Home Care | 1.8yrs | US$1.35m | 0.10% $ 373.9k | |
| Chief Executive Officer of Medicare Advantage | 1.3yrs | US$2.49m | 0.13% $ 486.4k | |
| Interim CFO | less than a year | sin datos | sin datos | |
| Chief Technology Officer | 2.3yrs | sin datos | 0.59% $ 2.2m | |
| Head of Investor Relations & Corporate strategy | no data | sin datos | sin datos | |
| Chief Compliance Officer | no data | sin datos | sin datos | |
| Chief People Officer | no data | sin datos | sin datos | |
| Chief Medical Officer of Clover Assistant | 2.5yrs | sin datos | sin datos | |
| Chief Medical Officer | 3.3yrs | sin datos | sin datos |
1.8yrs
Permanencia media
45yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de CLOV no se considera experimentado ( 1.5 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 9.8yrs | sin datos | 17.91% $ 65.7m | |
| Co-Founder | 5.5yrs | US$10.15m | 0.45% $ 1.6m | |
| Independent Director | 3.3yrs | US$280.93k | 0.067% $ 245.3k | |
| Independent Director | 7.3yrs | US$246.55k | 0.068% $ 248.3k | |
| Board Observer | no data | sin datos | sin datos | |
| Independent Director | 3.2yrs | US$268.43k | 0.051% $ 186.1k | |
| Independent Director | 1.8yrs | US$250.30k | 0.042% $ 152.5k | |
| Independent Director | 1.5yrs | US$247.80k | 0.072% $ 265.7k | |
| Lead Independent Director | 3.1yrs | US$320.16k | 0.045% $ 164.7k |
3.3yrs
Permanencia media
47yo
Promedio de edad
Junta con experiencia: La junta directiva de CLOV se considera experimentada (3.2 años de antigüedad promedio).